Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Regulatory News (AVCT)

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
73.00    -0.50 (-0.68%)
Bid:
72.00
Ask:
74.00
Spread: 2.00 (2.778%)
Market Cap: £342.04m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Sch 1 - Readybuy PLC

21 Jul 2006 10:15

AIM21 July 2006 ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH AIM RULE 2 ALL APPLICANTS MUST COMPLETE THE FOLLOWING: COMPANY NAME:Readybuy plc COMPANY ADDRESS:Television House, 10-12 Mount Street, Manchester COMPANY POSTCODE:M2 5NT COUNTRY OF INCORPORATION:England and Wales COMPANY BUSINESS OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTMENT STRATEGY TO BE DISCLOSED INACCORDANCE WITH SCHEDULE 2, PARAGRAPH (J) OF THE AIM RULES:Since the Readybuy group's trading activities were terminated in July 2005, the directors of Readybuy have beenexploring the future options available to the Company. The Company's investing strategy is to acquire a companyinvolved in developing enabling technologies, particularly in the defence and bio-chemistry sectors. The Boardbelieves that the proposed acquisition of Avacta meets this investment strategy. Avacta was spun-out from the University of Leeds in January 2004 by its current management team as a biophysicscompany, with the aim of combining the disciplines of physics and biology to develop innovative technologies toaddress needs in the homeland security, pharmaceutical and clinical diagnostic markets. Avacta has two core activities: the development of detection technology platforms designed to meet the needs ofits target markets; and the provision of analytical services relating to the chemical and physical analysis ofmaterials to a range of companies, principally in the pharmaceutical, healthcare and personal care sectors. DETAILS OF SECURITIES TO BE ADMITTED (i.e. where known, number of shares, nominal value and issue price to whichit seeks admission and the number and type to be held as treasury shares):644,857,446 ordinary shares of 0.1p each on First Admission 24,469,898 ordinary shares of 0.1p each on Second AdmissionCAPITAL TO BE RAISED ON ADMISSION:£1,012,500 before expenses, by means of a placing of 45,000,000 ordinary shares of 0.1p each at 2.25p per share FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS:Directors: Daron Ross Lee (non-executive Chairman) Professor David Alastair Maclaughlin Smith (non-executive director and proposed Chief Executive followingAdmission) Proposed Directors: Dr. Gwynfor Owen Humphreys (proposed non-executive Chairman)Dr. Simon Webster (proposed Chief Scientific Officer)Dr. Kurt Justin Baldwin (proposed Chief Technology Officer)Timothy James Sykes (proposed Chief Financial Officer and proposed Company Secretary)Professor Anthony William Robards (proposed non-executive director)Alan John Aubrey (propose non-executive director) PERSON(S) INTERESTED IN 3% OR MORE OF THE ISSUER'S CAPITAL, EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITALBEFORE AND AFTER ADMISSION:Before: Robert Quested (29.76%)Christopher Potts (16.96%)Stephen James (16.09%)Robert Quested, Christopher Potts and Stephen James are also interested in warrants to subscribe for 18,500,000;10,500,000; and 10,000,000 Ordinary Shares respectively. On Admission: Robert Quested (8.93%)Christopher Potts (3.15%)Stephen James (2.99%) The members of the Existing Concert Party, as at the date of this document, together hold 83.71% of the issuedshare capital of the Company, and will, immediately following the Placing and Admission hold 19.84 % thereof.The members of the New Concert Party (being the vendors of Avacta), as at the date of this document, togetherhold 0.96% of the issued share capital of the Company, and will, immediately following the Placing and Admissionhold 74.88% thereof. NAMES AND ADDRESSES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:None ANTICIPATED ACCOUNTING REFERENCE DATE:30 April EXPECTED ADMISSION DATE:8 August 2006 (First Admission)9 August 2006 (Second Admission) NAME AND ADDRESS OF NOMINATED ADVISER:WH Ireland Limited11 St James's SquareManchesterM2 6WH NAME AND ADDRESS OF BROKER:WH Ireland Limited11 St James's SquareManchesterM2 6WH DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENTTHAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:Copies of the admission document containing full details about the applicant and the admission of its securitieswill be available free of charge to the public until at least one month after admission at the offices of:- WH Ireland Limited11 St James's SquareManchesterM2 6WH DATE OF NOTIFICATION:21 July 2006 NEW/ UPDATE (see note):New This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Aug 20097:00 amPRNPre-Close Trading Statement
28th Jul 20095:07 pmRNSHolding(s) in Company
13th Jul 20094:40 pmRNSDirector/PDMR Shareholding
10th Jul 20094:17 pmRNSIssue of Equity
9th Jul 20094:29 pmRNSFurther re Acquisition of Theragenetics Limited
23rd Apr 20097:00 amRNSHalf Yearly Report
23rd Apr 20097:00 amPRNOPTIM Product Launch
31st Mar 200912:20 pmPRNAnalyst Presentation
30th Mar 200912:59 pmPRNDirector/PDMR Shareholding
3rd Mar 20091:17 pmRNSCompletion of Acquisition of Curidium Medica plc
2nd Mar 200912:00 pmRNSResult of Court Hearing
12th Feb 20091:23 pmRNSRule 8.1- (Curidium Medica Plc)
11th Feb 20092:09 pmRNSResults of meetings
9th Feb 200912:39 pmRNSResult of EGM
9th Feb 20097:00 amPRNAcquisition
26th Jan 20097:00 amPRNResult of AGM
16th Jan 20097:00 amRNSOffer Update
15th Jan 20099:24 amPRNAcquisition of Theragenetics Limited
9th Jan 200910:12 amRNSAvacta Group plc Acquisition
9th Jan 20097:00 amPRNAcquisition(s)
8th Jan 20092:29 pmRNSDirector/PDMR Shareholding
7th Jan 20097:00 amRNSIssue of Equity
12th Dec 200812:06 pmRNSFinal Results
20th Nov 20084:14 pmRNSDirector/PDMR Shareholding
5th Nov 200812:42 pmRNSIssue of Equity
4th Nov 20087:00 amPRNFinal Results
13th Oct 20087:00 amPRNChange of Adviser
11th Sep 20087:00 amPRNProduct Launch
21st Aug 20087:00 amPRNTrading Statement
14th Aug 200811:03 amPRNProduct Development Partnership
28th Jul 20087:00 amPRNProduct Launch
23rd Jul 20082:54 pmPRNDirector/PDMR Shareholding
14th Apr 20087:00 amPRNHalf-yearly Report
4th Apr 20085:20 pmRNSDirector/PDMR Shareholding
31st Mar 20087:00 amRNSTotal Voting Rights
10th Mar 20083:12 pmRNSIssue of Equity
31st Jan 200811:36 amRNSTotal Voting Rights
7th Jan 200810:50 amPRNRe Agreement
31st Dec 20077:00 amPRNTotal Voting Rights
14th Dec 20073:30 pmPRNAcquisition(s)
14th Dec 20073:05 pmPRNAGM Statement
21st Nov 20077:01 amRNSNotice of AGM
14th Nov 20079:08 amPRNAcquisition
9th Nov 20074:59 pmPRNDirectorate Appointment
25th Sep 20077:00 amPRNFinal Results
3rd Sep 20077:00 amPRNRe Agreement
14th Aug 20073:59 pmRNSAIM Rule 26 Information
13th Aug 20077:00 amPRNRe Agreement
31st Jul 20073:37 pmRNSTotal Voting Rights
26th Jul 20079:53 amPRNIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.